Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986590 · ClinicalTrials.gov registry record · NA

Addressing Hypertension Care in Africa Program

A NA study of Hypertension and High Blood Pressure, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
17
Study locations

NCT06986590: Recruiting NA study of Hypertension and High Blood Pressure, sponsored by Johns Hopkins University.

NCT06986590 is a NA study of Hypertension and High Blood Pressure that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 800 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (77% lower). The trial reports 17 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986590, a NA study of Hypertension and High Blood Pressure, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
17
Study locations

Study Summary

The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.

Primary Outcome

Blood pressure control among participants defined as systolic blood pressure \<140 mmHg

Interventions

  • BEHAVIORAL ADHINCRA Program

Study Locations (17)

Ondo State

  • Akure South Hospital - Akure
  • Akoko North East - Ondo
  • Akoko North West - Ondo
  • Akoko South East - Ondo
  • Akoko South West - Ondo
  • Owo General Hospital - Owo

Ashanti Region

  • Dominase SDA Hospital - Bekwai
  • Kumasi South Hospital - Kumasi
  • Manhyia Government Hospital - Kumasi
  • Tafo Government Hospital - Tafo

Bono

  • Berekum Holy Family Hospital - Berekum
  • St. John of God Catholic Hospital - Duayaw Nkwanta

Northern Region

  • Northern Regional Hospital - Tamale
  • Tamale Teaching Hospital - Tamale

Volta Region

  • Ho Municipal Hospital - Ho
  • South Tongu District Hospital - Sogakope

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2026-01-09
Est. Completion 2028-09
Phase NA
Johns Hopkins University

1,448 total trials

What NCT06986590 shows while recruiting

NCT06986590 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which ADHINCRA Program is the first listed.

NCT06986590 lists 17 locations in 6 states (Ondo State, Ashanti Region, Bono).

Frequently Asked Questions

What is clinical trial NCT06986590 about?

NCT06986590 is a clinical study titled "Addressing Hypertension Care in Africa Program". The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model fo...

What is the current status of trial NCT06986590?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2026-01-09. Estimated completion is 2028-09.

What conditions does trial NCT06986590 study?

This clinical trial studies the following conditions: Hypertension, High Blood Pressure.

What interventions are being tested in trial NCT06986590?

The interventions under investigation include: ADHINCRA Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06986590?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986590 being conducted?

This trial has 17 study locations across Maryland, Ashanti Region, Bono, Northern Region, Volta Region. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06986590's enrollment target sits among peer trials

800 88th of 470 higher than 382 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06986590, the US trial registry maintained by the National Library of Medicine. NCT06986590 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.